ClinicalTrials.govpublic full text
Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
drug safety, sepsis, inflammation, complement, immune system, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010327
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.